Increased nuclear DNA damage precedes mitochondrial dysfunction in peripheral blood mononuclear cells from

Georgina Askeland1,2, Zaneta Dosoudilova3, Marie Rodinova3

  • 1Department of Medical Biochemistry, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Scientific Reports
|July 1, 2018
PubMed

Insights

Huntington's disease (HD) involves impaired aerobic metabolism and reduced mitochondrial activity. Nuclear DNA damage significantly increases in HD patients, correlating with disease severity and offering a potential biomarker.

Area of Science:

  • Genetics
  • Neuroscience
  • Cell Biology

Background:

  • Huntington's disease (HD) is a neurodegenerative disorder caused by CAG repeat expansion in the huntingtin gene.
  • Current biomarkers for HD are limited, necessitating the identification of new markers for disease progression and therapeutic monitoring.

Purpose of the Study:

  • To investigate mitochondrial and nuclear DNA (mtDNA and nDNA) parameters as potential biomarkers in peripheral blood mononuclear cells (PBMCs) of HD patients.
  • To explore cellular impairments, including metabolic and genomic integrity, associated with Huntington's disease.

Main Methods:

  • Analysis of gene expression related to aerobic metabolism in PBMCs from HD patients and controls.
  • Quantification of mtDNA damage frequency and assessment of nDNA modification levels.
  • Correlation of genomic damage with the Total Functional Capacity (TFC) score in HD patients.

Main Results:

  • A general suppression of aerobic metabolism genes was observed in HD patient PBMCs.
  • Decreased levels of factors for mitochondrial biogenesis and reduced mtDNA damage frequency suggest early mitochondrial dysfunction.
  • HD patients exhibited a four-fold increase in nDNA modification compared to controls, with nDNA damage inversely correlating with TFC score.

Conclusions:

  • PBMCs represent a viable source for monitoring Huntington's disease progression.
  • Increased nDNA damage and distinct mitochondrial and nuclear genome responses indicate early cellular impairments in HD.
  • These findings highlight nDNA damage as a potential biomarker for HD severity and progression.

Related Concept Videos

Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...